“CAR T-Cell Therapy Outcomes and Toxicity Profiles in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia”, ALR, vol. 6, no. 1, pp. 10–15, Aug. 2025, doi: 10.5281/zenodo.22238163.